Literature DB >> 15574055

Evaluation of Australia's National Notifiable Disease Surveillance System.

Megge Miller1, Paul Roche, Jenean Spencer, Mary Deeble.   

Abstract

The Australian National Notifiable Diseases Surveillance System (NNDSS) is a passive surveillance system that collects information on communicable diseases. The Australian Government manages NNDSS under the auspices of the Communicable Diseases Network Australia (CDNA). Data collected by each state and territory are collated, analysed and disseminated by the Australian Government Department of Health and Ageing. We report the first evaluation of NNDSS since it was established in 1991. Three primary stakeholder groups were surveyed: (a) CDNA members, (b) the National Surveillance Committee and (c) the readership of Communicable Diseases Intelligence, the primary means of data dissemination from NNDSS. The evaluation revealed that the system was acceptable, structurally simple, and that the data collected were actively used by stakeholders. However, the lack of clearly documented aims and objectives for NNDSS, inflexibility to changing needs, lack of timeliness and complexity in processes were seen as problematic. The results of this evaluation, supported by recent federal funding to enhance national biosecurity, will provide the framework for enhancing NNDSS to meet national communicable disease surveillance requirements in Australia.

Entities:  

Mesh:

Year:  2004        PMID: 15574055

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  15 in total

1.  Feasibility of implementing recommendations to improve communicable diseases surveillance--a modified Delphi study.

Authors:  N Sahal; R Reintjes; E M Eltayeb; A R Aro
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

2.  Syndromic surveillance for local outbreaks of lower-respiratory infections: would it work?

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Wilfrid van Pelt; Gerda Doornbos; Nico J D Nagelkerke; Gé A Donker; Wim van der Hoek; Marion P G Koopmans
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

3.  Australia's National Notifiable Diseases Surveillance System 1991-2011: expanding, adapting and improving.

Authors:  K B Gibney; A C Cheng; R Hall; K Leder
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

4.  A surveillance sector review applied to infectious diseases at a country level.

Authors:  Michael G Baker; Sally Easther; Nick Wilson
Journal:  BMC Public Health       Date:  2010-06-11       Impact factor: 3.295

5.  Using GIS to create synthetic disease outbreaks.

Authors:  Rochelle E Watkins; Serryn Eagleson; Sam Beckett; Graeme Garner; Bert Veenendaal; Graeme Wright; Aileen J Plant
Journal:  BMC Med Inform Decis Mak       Date:  2007-02-14       Impact factor: 2.796

6.  Survey of Communicable Diseases Surveillance System in Hospitals of Iran: A Qualitative Approach.

Authors:  Nayeb Fadaei Dehcheshmeh; Mohammad Arab; Abbas Rahimi Fouroshani; Fereshteh Farzianpour
Journal:  Glob J Health Sci       Date:  2016-09-01

7.  Survey of the perceptions of key stakeholders on the attributes of the South African Notifiable Diseases Surveillance System.

Authors:  F G Benson; A Musekiwa; L Blumberg; L C Rispel
Journal:  BMC Public Health       Date:  2016-10-25       Impact factor: 3.295

8.  Varicella-Zoster Virus in Perth, Western Australia: Seasonality and Reactivation.

Authors:  Igor A Korostil; David G Regan
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

9.  Validation of syndromic surveillance for respiratory pathogen activity.

Authors:  Cees van den Wijngaard; Liselotte van Asten; Wilfrid van Pelt; Nico J D Nagelkerke; Robert Verheij; Albert J de Neeling; Arnold Dekkers; Marianne A B van der Sande; Hans van Vliet; Marion P G Koopmans
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

Review 10.  Communicable Disease Reporting Systems in the World: A Systematic Review Article.

Authors:  Ali Janati; Mozhgan Hosseiny; Mohammad Mehdi Gouya; Ghobad Moradi; Ebrahim Ghaderi
Journal:  Iran J Public Health       Date:  2015-11       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.